Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 165
Selected: 0
NCT IDTitle
NCT00508586PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
NCT02318186Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)
NCT06450041NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
NCT02583789Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
NCT01353027Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
NCT00741819Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
NCT05848687TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
NCT02074449Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)
NCT073912155G-PEARL: Paxalisib in Malignant Brain Tumours
NCT03888365Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
NCT00969722A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients
NCT03481725Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study
NCT02999906Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension
NCT06388421DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT05060315Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
NCT01273922Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida
NCT02573896Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
NCT03497689EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
NCT00963001Effect of Food on the Pharmacokinetics of Oral Treprostinil
NCT00705133Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
NCT0006951112 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
NCT05564637A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
NCT06425796Adiposity and Iron Requirements in Pregnancy
NCT01593072A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
NCT02630316Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
NCT04246281The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain
NCT06059118Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
NCT01266265Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
NCT04478071Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
NCT02633293An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
NCT05735249A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects
NCT05776225Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
NCT03037580Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
NCT05255991Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT01750684AC105 in Patients With Acute Traumatic Spinal Cord Injury
NCT00760916FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT00651885Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure
NCT03055234Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)
NCT00775463Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
NCT03367312Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
NCT00004497Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
NCT01131845The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil
NCT01353040Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
NCT01795950Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
NCT01165476Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities
NCT01934582A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
NCT03814317Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
NCT04905693Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT06911632Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
NCT01268553Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication